Rischin, D., King, M., Kenny, L., Porceddu, S., Wratten, C., Macann, A., . . . Corry, J. (2021). Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study. International journal of radiation oncology, biology, physics, 111(4), 876-886. https://doi.org/10.1016/j.ijrobp.2021.04.015
Chicago Style (17th ed.) CitationRischin, Danny, et al. "Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study." International Journal of Radiation Oncology, Biology, Physics 111, no. 4 (2021): 876-886. https://doi.org/10.1016/j.ijrobp.2021.04.015.
MLA (9th ed.) CitationRischin, Danny, et al. "Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study." International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 4, 2021, pp. 876-886, https://doi.org/10.1016/j.ijrobp.2021.04.015.